US Biologics Debate Heats Up As Congress, Obama, Wrangle With Healthcare Reform
As the United States Congress prepares to recess in early August, there's hope - and dread, depending on which “side” of the debate you’re on - that legislation creating a regulatory pathway for follow-on biologics may be pushed through as part of the broader healthcare reform package.

The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The July edition is now available for subscribers.
In a short videocast, Lammy offers his views on global public policy, patent backlogs, patent pools and the role of WIPO.
Interview With Ellen ‘t Hoen, Senior IP Advisor At UNITAID, author of "The Global Politics of Pharmaceutical Monopoly Power."